Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

G. Ruiz-Irastorza; M. J. Cuadrado; I. Ruiz-Arruza; R. Brey; M. Crowther; R. Derksen; D. Erkan; S. Krilis; S. Machin; V. Pengo; S. Pierangeli; M. Tektonidou; M. Khamashta

doi:10.1177/0961203310395803

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

G. Ruiz-Irastorza, M. J. Cuadrado, I. Ruiz-Arruza, R. Brey, M. Crowther, R. Derksen, D. Erkan, S. Krilis, S. Machin, V. Pengo, S. Pierangeli, M. Tektonidou, M. Khamashta

Women & Children's Health

Research output: Contribution to journal › Article › peer-review

413 Citations (Scopus)

Abstract

The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.

Original language	English
Pages (from-to)	206 - 218
Number of pages	13
Journal	Lupus
Volume	20
Issue number	2
DOIs	https://doi.org/10.1177/0961203310395803
Publication status	Published - Feb 2011

Access to Document

10.1177/0961203310395803

Fingerprint

Dive into the research topics of 'Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies'. Together they form a unique fingerprint.

Cite this

Ruiz-Irastorza, G., Cuadrado, M. J., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V., Pierangeli, S., Tektonidou, M., & Khamashta, M. (2011). Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies. Lupus, 20(2), 206 - 218. https://doi.org/10.1177/0961203310395803

@article{66b9b588eb9746a490dfd1387115d346,

title = "Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies",

abstract = "The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.",

author = "G. Ruiz-Irastorza and Cuadrado, {M. J.} and I. Ruiz-Arruza and R. Brey and M. Crowther and R. Derksen and D. Erkan and S. Krilis and S. Machin and V. Pengo and S. Pierangeli and M. Tektonidou and M. Khamashta",

year = "2011",

month = feb,

doi = "10.1177/0961203310395803",

language = "English",

volume = "20",

pages = "206 -- 218",

journal = "Lupus",

publisher = "SAGE Publications Ltd",

number = "2",

}

Ruiz-Irastorza, G, Cuadrado, MJ, Ruiz-Arruza, I, Brey, R, Crowther, M, Derksen, R, Erkan, D, Krilis, S, Machin, S, Pengo, V, Pierangeli, S, Tektonidou, M & Khamashta, M 2011, 'Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies', Lupus, vol. 20, no. 2, pp. 206 - 218. https://doi.org/10.1177/0961203310395803

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies. / Ruiz-Irastorza, G.; Cuadrado, M. J.; Ruiz-Arruza, I. et al.
In: Lupus, Vol. 20, No. 2, 02.2011, p. 206 - 218.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

AU - Ruiz-Irastorza, G.

AU - Cuadrado, M. J.

AU - Ruiz-Arruza, I.

AU - Brey, R.

AU - Crowther, M.

AU - Derksen, R.

AU - Erkan, D.

AU - Krilis, S.

AU - Machin, S.

AU - Pengo, V.

AU - Pierangeli, S.

AU - Tektonidou, M.

AU - Khamashta, M.

PY - 2011/2

Y1 - 2011/2

N2 - The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.

AB - The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.

U2 - 10.1177/0961203310395803

DO - 10.1177/0961203310395803

M3 - Article

VL - 20

SP - 206

EP - 218

JO - Lupus

JF - Lupus

IS - 2

ER -

Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies. Lupus. 2011 Feb;20(2):206 - 218. doi: 10.1177/0961203310395803